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LEUKOCYTE AND PLATELET 
DEPLETION WITH A BLOOD 
CELL SEPARATOR: EFFECTS 
ON LUNG INJURY AFTER 
CARDIAC SURGERY WITH 
CARDIOPULMONARY 
BYPASS 
This study was undertaken to assess the etfects of leukocyte and platelet 
depletion on postoperative lung injury in 42 patients who underwent heart 
operations. Blood was serially samp|ed before, during, and after cardiopul- 
monary bypass, and leukocyte count, platelet count, and thromboxane B 2 
6-keto-PGFl«, leukocyte lastase, thrombin-antithrombin III complex, and 
D-dimer levels were determined. Postoperative r spiratory function was 
assessed based on analyses of oxygenation and carbon dioxide elimination. 
Leukocyte and platelet depletion was performed in 21 patients (experimen- 
tal group) but not in another (control group). In the experimental group, 
leukocytes and platelets were removed continuously by means of the blood 
cell separator CS-3000, beginning immediately after the start of the 
operation and ending I hour after the release of aortic occ]usion. Leukocyte 
elastase, thromboxane B2, ratio of thromboxane B2 to 6-keto-PGFm, 
thrombin-antithrombin II1 complex, and D-dimer were significantly ower 
in the experimental group than in the control group. Of the various indexes 
of oxygenation, arterial oxygen tension was significantly higher in the 
experimental group and the alveolar-arterial oxygen pressure difference 
and respiratory index were significantly lower in the experimental group. 
The positive end-expiratory pressure needed to achieve an appropriate 
arterial oxygen tension was significantly lower in the experimental group. 
The elimination of carbon dioxide was lower in the experimental group. 
Depletion of leukocytes and platelets reduced respiratory dysfunction after 
heart operations with cardiopulmonary b pass. It was particularly effective 
in patients with a low preoperative oxygenation capacity and in those for 
whom an extended period of cardiopulmonary b pass was required. 
(J T~IORAC CARDIOVASC SURG 1996;111:45-54) 
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L eukocytes have been reported to play a major role in "postperfusion lung syndrome," respira- 
tory dysfunction after heart operations with cardio- 
pulmonary bypass. 1 Recent animal studies 2 have 
demonstraled that the removal of leukocytes is 
effective in preventing reperfusion injury to the 
ischemic heart. However, few clinical studies have 
been perf0rmed regarding the effects of leukocyte 
removal on respiratory function after heart opera- 
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tions with cardiopulmonary b pass. Although other 
studies have reported the effects of preoperative 
collection of the patient's own platelets on reduction 
of bleeding after heart operations and on the coag- 
ulation system, 3'4 no studies have examined how 
respiratory function is affected by the leukocytes and 
the platelets and their interaction. We recently have 
attempted continuous leukocyte and platelets deple- 
tion (LPD) by means of a blood ceU separator 
during heart operations, beginning immediately af- 
ter the start of operation. After the end of cardio- 
pulmonary bypass, we serially evaluated the respira- 
tory function of these patients to assess the effects of 
LPD. 
Patients and methods 
The subjects were 42 adults who underwent heart 
operations. They were divided into two groups at random: 
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Table I. Patient characteristics and operative pararneters 
LPD group (n = 21) Control group (n = 21) p 
Age (yr) 62.6 _+ 13.6 60.5 _+ 13.8 NS 
Sex (M/F) 11/10 12/9 NS 
Height (cm) 157 _+ 8.6 158 _+ 8 NS 
Weight (kg) 58.7 +_ 11.8 60.9 _+ 13.7 NS 
CABG 12 14 NS 
AVR or MVR 9 7 NS 
CPB time (min) 171 +_ 60 152 _+ 34 NS 
Aortic crossclamp time (min) 112 _+ 40 99 +- 28 NS 
Minimal rectal temperature (° C) 22.1 _+ 2.1 22.3 _+ 1.8 NS 
Data are mean -+ standard deviation. NS, Not significant; CABG, coronary artery bypass grafting; AVR, aortic valve replacement; MVR, rnitral valve 
replacernent. 
the LPD group (21 patients in whom LPD was performed) 
and the control group (21 patients in whom LPD was not 
performed). In the LPD group, 12 patients underwent 
palliative coronary artery bypass grafting and nine under- 
went valve replacement. In the control group, 14 patients 
underwent coronary artery bypass grafting and seven 
underwent valve replacement. There were no significant 
differences between the two groups in terms of male-to- 
female ratio, age, duration of operation, duration of aortic 
occlusion, duration of cardiopulmonary b pass, or mini- 
mal rectal temperature (Table I). After the operation was 
started, a 10F venovenous hunt catheter was inserted 
percutaneously into the femoral vein to start continuous 
LPD by means of a blood cell separator (CS-3000; Baxter 
Healthcare Cõrp., Fenwal Autophor, Irvine, Calif.). The 
blood flow rate during LPD (50 ml/min) did not affect any 
patient's hemodynamic condition. The contents of the 
centrifuge were rotated at 1000 rpm. LPD was continued 
until 1 hour after the release of aortic occlusion. At 3 to 6 
hours after the release of aortic occlusion, a fluid contain- 
ing a high concentration of the removed leukocytes and 
platelets was returned through a peripheral vein. Opera- 
tions were performed with the patient placed under 
anesthesia with high doses of fentanyl citrate (Fentanest), 
administered by means of a Narkomed 2A device (Drä- 
gerwerk AG, Lübeck, Germany). A membranous oxygen- 
ator (Bentley UNIVOX; Baxter, Fenwal Autophor) was 
used for cardiopulmonary bypass. The extracorporeal 
circuit was filled with a leukocyte-free rythrocyte prepa- 
ration. In all cases, operations were performed with the 
patient in cardiac arrest with cold blood cardioplegia. 
During cardiopulmonary b pass, the flow rate was main- 
tained at 2.4 L .  min -1 .  m -2 body surface area and the 
arterial was maintained pressure at 55 to 65 mm Hg. After 
operation, the patients were cared for in the intensive care 
unit, where a Servo ventilator 900C (Siemens-Elema AB, 
Solna, Sweden) was used for assisted ventilation at a tidal 
volume of 10 tal/kg and a respiratory rate of 10 to 12 
breaths/min. 
Blood was sampled 5 minutes before and 5 minutes 
after the start of cardiopulmonary bypass, 2 minutes 
before the release of aortic occlusion, and 2 minutes, 15 
minutes, 30 minutes, 1hour, 3 hours, 6 hours, 12 hours, 24 
hours, and 48 hours after the release of aortic occlusion. 
Blood gas analysis was performed within 30 minutes after 
the start of operation and 1 hour, 3 hours, 4 hours, 6 
hours, 12 hours, and 18 hours after the release of aortic 
occlusion. 
The levels of thromboxane B2 (TxBz), 6-keto-PGFt~, 
leukocyte elastase, complements (C3a, C4a, and C5a), 
thrombin-antithrombin III complexes (TAT), and D-dimer 
were measured in every blood sample. The leukocyte and 
platelet counts were determined in blood samples collected 
in a tube treated with sodium ethylenediamine tetraacetic 
acid (EDTA-Na2). The TxB a and 6-keto-PGFl~ levels were 
measured by an antigen-antibody reaction with the radioim- 
munoassay-polyethylene glycol method. 5 For the measure- 
ment of these two parameters, blood was coUected into a 
special test tube containing EDTA-Na2 and indomethacin 
and was then immediately centrifuged at 4 ° C for 20 minutes, 
The separated plasma was stored frozen at -70°C until 
assay. For the measurement of leukocyte lastase, blood was 
collected into a sampling tube containing EDTA-Na2 and 
the plasma was separated from it within 1 hour of collection. 
The separated plasma was stored frozen at -70 ° C until it 
was used for the measurement of the elastase concentration 
by enzyme immunoassay, a method that uses the binding of 
antibody to elastase and elastase al-proteinase inhibitor 
complex. Complement (C3a, C4a, and C5a) cõncentrations 
were measured with a radioimmunoassay (two-antibody 
method) that involves antigen-antibody reactions. ó The 
TxB2, 6-keto-PGFl~, leukocyte lastase, C3a, C4a, and C5a 
concentrations were measured at a laboratory center (SRL, 
Tokyo, Japan). As indexes of respiratory function, the arte- 
rial oxygen tension (Pao2), alveolar-arterial oxygen differ- 
ence (A-aDo2) , respiratory index (RI) and positive end- 
expiratory pressure (PEEP) were compared between the two 
groups. The elimination of carbon dioxide (EIcOz) was 
calculated by means of the following equationT: 
Paco2 - PETCO 2 
EIco2 = Paco2 
where PETCO 2 is the concentration of end-tidal carbon 
dioxide. 
Blood collected through a catheter inserted into the 
radial artery was subjected to gas analysis with an ABL330 
(Radiometer A/S, Copenhagen, Denmark). Each group 
was subdivided into two subgroups depending on the 
duration of cardiopulmonary bypass: one group had 
a duration of less than 160 minutes and one group had a 
duration of more than 160 minutes. The respiratory 
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Fig. 1. Leukocyte count and platelet count in the control and leukocyte and platelet depleted groups 
before operation, 2 minutes before crossclamp removal and at various other times. Asterisk signifies p < 
0.05; Tnple asterisk signifies p < 0.005 compared with the LPD group. Data are mean _+ SEM. CPB, 
Cardiopulmonary b pass. 
functions of the patients in these two groups after the end 
of cardiopulmonary b pass were compared. The patients 
also were subdivided into two groups depending on pre- 
operative oxygen tension (measured after the induction of 
general anesthesia at an inspired oxygen fraction of 1.0): 
one subgroup had Pao2 greater than 520 mm Hg and one 
subgroup had Pao 2 less than 520 mm Hg. All parameters 
were expressed as the mean ± standard error of the mean 
(SEM). Repeated-measures analysis of variance and un- 
paired Student's t test was used to test the significance of 
differenceso A p value less than 0.05 was regarded as 
statistically significant. 
Results 
The mean duration of LPD in the LPD group was 
296 + 81 minutes. The mean total number of 
leukocytes removed was 3.4 ± 2.1 × 10 l°, which is 
equivalent to 119% _+ 46% of the estimated number 
of leukocy~es in the circulating blood. The mean 
number of platelets removed was 2.8 ± 1.2 × 1011, 
which is equivalent to 27% ± 10% of the estimated 
number of platelets in the circulating blood. The 
leukocyte count in the peripheral blood was signif- 
icantly lower in the LPD group than in the control 
group 2 minutes before (1.8 ± 0.2 × 102 vs 3.6 ± 
0.4 × 102 cells//.d) and 2 minutes (1.9 + 0.3 × l0 s vs 
3.3 ± 0.5 ×: 102 cells/pJ) and 15 minutes after (1.9 ± 
0.4 × 102 vs 3.8 ± 0.7 × 102 cells//xl) the release of 
aortic occlusion (Fig. 1). The platelet count in the 
peripheral blood was significantly lower in the LPD 
group 2 minutes before (4.4 + 2.0 × 10 4 vs 8.1 + 
3.3 × 104 cells//xl) and 2 minutes (4,5 _+ 2.0 × 104 vs 
7.8 ± 3.5 × 104 cells//xl), 15 minutes (4.9 + 2.3 × 104 
vs 8.8 --+ 4.0 × 104 cells/~l) and 30 minutes (5.4 + 
2.1 × 104 vs 10.1 + 4.8 × 104 celis//xl), 1 hour (5.8 + 
2.8 X ]04 VS 10.5 + 4.2 × 104 cells/~l) and 3 hours 
(8.2 ± 3.6 × 104 vs 13.2 ± 5.1 × 104 cells//xl) after 
the release of aortic occlusion (Fig. 1). The leuko- 
cyte elastase level was significantly lower in the LPD 
group than in the control group 2 minutes before 
(0.88 + 0.16 × 103 vs 1.47 + 0.64 × 103 ng/ml), and 
1 hour (1.63 _+ 0.21 × 103 vs 2.64 + 0.24 × 103 
ng/ml) and 3 hours (1.49 ± 0.29 × 103 vs 1.84 ± 0.27 
X 103 ng/ml) after the release of aortic occlusion 
(Fig. 2). No significant intergroup difference was 
noted in 6-keto-PGFl~ levels. The TxB 2 level was 
significantly lower in the LPD group than in the 
c0ntrol group at 1 hour (152 + 26 vs 276 + 54 
pg/mi), 6 hours (71 ± 18 vs 96 ± 18 pg/ml), and 12 
hours (34 + 4.4 vs 50 ± 6.3 pg/ml) after the release 
of aortic occlusion (Fig. 3). The ratio of TxB 2 to 
6-keto-PGFl~ was significantly lower in the LPD 
group 2 minutes before (1.49 _+ 0.12 vs 2.23 _+ 0.48) 
and 1 hour (1.45 _+ 0.16 vs 1.98 ± 0.35), 6 hours 
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the LPD group. Intervals are as in Fig. 1. Data are mean ± SEM. CPB, Cardiopulmonary bypass. 
(1.57 _+ 0.22vs 2.88 _+0.52), and 12 hour s (1.28 _+ 0.14 
vs 2.3 + 0.45) after the release of aortic occlusion (Fig. 
3). The D-dimer concentration was significantly lower 
in the LPD group from 5 minutes after the start of 
pumping to 24 hours after the release of aortic occlu- 
sion (Table II). TAT was significantly lower in the 
LPD group at 5 minutes after the start of pumping and 
1 hour after the release of aortic occlusion (Table II). 
No significant intergroup differences were observed in 
the complement (C3a, C4a, and C5a) levels. 
In the LPD group, there was no significant dif- 
ference between preoperative änd postoperative 
Pao~; however, the Pa02 was significantly better in 
the LPD group than in the control group ät 1, 3, 
and 4 hours after the release of aortic occlusion 
(Table ilI). Starting from the sixth tiour after the 
ielease of aortic occlusion, the Pao2 levels were 
approximately equal to the preoperative l vels in 
both groups and did not differ between the groups. 
In the LPD group, the RI measured at 1, 3, and 4 
hours after the release of aortic occlusion was 
significantly ower than the preoperative l vel (Ta- 
ble III). PEEP, which was measured after operation, 
was significantly lower in the LPD group than in the 
control group at 4, 6, 12, and 18 hours after the 
release of aortic occlusion (Table III), In the same 
group, the EIco2 differed significantly from the 
preoperative l vel at 1 hour (166% _+ 38.3% vs 
593% + 121%), 6 hours (67% + 25% vs 406% + 
135%), and 18 hours (72% +_ 27% vs 257% + 80%) 
after the release of aortic occlusion (Fig. 4). In 
patients in whom the preoperative Pao 2 was greater 
than 520 mm Hg at an inspired oxygen fraction of 
1.0, the Pao 2 after the release of aortic occlusion did 
not differ significantly between the LPD group and 
the control group. In patients in whom the preop- 
erative Pao2 was less than 520 mm Hg, however, this 
parameter atI hour (115% _+ 7.1% vs 83% ___ 5,3%) 
and 3 hours (103% + 3.1% vs 79% _+ 8%) after the 
release, of aortic occlusion was significantly better 
in the LPD group than in the control group (Fig. 
5). In patients in whom the duration of cardiopul- 
monary bypass was less than 160 minutes, the 
postoperative Pao a did not differ significantly 
between the LPD and control groups. In patients 
in whom the duration was greater than 160 min- 
utes, however, this parameter was significantly 
better in the LPD group than in the control group 
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Table II. Perioperative change in D-dimer and TAT 
D-dimer TAT 
LPD Control LPD Control 
Before CPB 
5 min aßer CPB 
2 min before crossclamp removal 
2 min after crossclamp removal 
15 min after crossclamp removal 
30 min after crossclamp removal 
1 hr after crossclamp removal 
3 hr after crossclamp removal 
6 hr after crossclamp removal 
12 hr after crossclamp removal 
24 hr after crossclamp removal 
48 hr after crossclamp removal 
1.6 + 0.7 1.7 -+ 0.4 7.3 -+ 1.9 9.0 -+ 1.8 
5.7 -+ 1.3" 11.7 -+ 2.8 66.8 ± 6.9* 94.0 -+ 11.2 
7.8 -+ 1.3" 13.0 -+ 2.1 86.6 -- 7.9 105.0 -+ 8.7 
8.1 -+ 1.4" 13.5 -+ 2.3 92.5 -+ 7.5 107.7 -+ 8.7 
8.7 -+ 1.5" 16.2 -+ 2.9 92.6 -+ 7.1 100.5 -+ 7.7 
9.2 -+ 1.5" 17.4 + 3.4 93.5 -+ 6.8 107.9 _+ 8.0 
9.2 -+ 1.7t 19.5 + 3.8 86.0 ± 27.4* 111.2 ± 9.1 
5.3 -+ 1.1" 10.9 + 2.2 58.2 ± 7.1" 73.2 ± 7.6 
3.8 ± 0.7* 7.4 ± 1.6 47.9 ± 8.2 36.5 ± 7.7 
2.4 -+ 0.4* 4.7 + 0.8 18.5 -+ 6.9 19.2 ± 5.6 
1.7 -+ 0.3* 3.4 -+ 0.8 21.0 + 3.2 23.3 ± 9.1 
1.2 ± 0.4 3.6 + 1.3 10.6 ± 7.8 5.1 ± 1.8 
Data are mean _+ SEM. CPB, Cardiopulmonary b pass. 
*p < 0.05 vs control. 
+p < 0.005 vs control. 
at 1 hour (108% _+ 6.9% vs 79% _+ 7.1%) and 3 
hours (95% _+ 6.5% vs 77% _+ 7.1%) after the 
release of aortic occlusion (Fig. 6). 
Discussion 
Lung injury after heart operations has been re- 
ported to involve various factors, such as comple- 
ment, platelets, endothelial cells, and inflammatory 
substances released from cells. 8' 9 Leukocytes are 
activated by complement and other factors during 
cardiopulmonary b pass, and leukocyte sequestra- 
tion occurs primarily in the lüßgg, a° At reperfusion, 
these activated leukocytes release proteases and 
oxygen free radicals, which destroy the tissue. The 
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Table III. Perioperative change in Pao 2 and in RI and PEEP necessary to ensure adequate Pao 2 
Pao2* RI 
LPD Control 
PEEP (cm HsO) 
LPD Control LPD Control 
Fio2 100% 100% 
Before operation 515 -+ 20 mm Hg 532 _+ 15 mm Hg 0.4 + 0.04 0.3 ± 0.05 
After operation 
1 hr 106% ± 4.8%t" 85.1% ± 4.4% 0.2 ± 0.05:~ 0.6 ± 0.09 
3 hr 99.4% + 3.7%$ 82.4% ± 5.5% 0.3 _+ 0.055 0.6 ± 0.13 
4 hr 102% ± 1.4%$ 88.4% + 6.8% 0.4 +_ 0.05:~ 0.8 ± 0.18 
6 hr 99.1% ± 4.7% 95.6% ± 4.0% 0.4 ± 0.07:~ 0.5 ± 0.07 
12 hr 99.7% ± 3.0% 87.2% ± 7.6% 0.4 ± 0.05 0.7 ± 0.09 
18 hr 105% + 5.7% 98.5% ± 4.7% 0.6 ± 0.12 0.7 ± 0.10 
2.1 -+ 0.3§ 3.3 -+ 0.3 
2.2 ± 0.3§ 3.3 -+ 0.3 
2.2 _+ 0.3§ 3.3 -+ 0.2 
1.9 + 0.3§ 3.3 +- 0.3 
Data are mean -+ SEM. Fio» Inspired oxygen fraction. 
*Value before operation isbaseline; values after operation are percentages ofbaseline. 
?p < 0.005 vs control. 
:~p < 0.05 vs control. 
§p < 0.01 vs control. 
level of leukocyte !astase, a protease, was signifi- 
cantly lower in the LPD group in this study. Elas- 
tase-mediated injury to the endothelia] cells of 
pulmonary vessels and to pulmonary epithelial cells 
has been previously reported. 11 In this study, the 
removal of leukocytes and platelets eemed to re- 
duce the elastase-mediated adverse ffects as well as 
postoperative lung injury. 
During cardiopulmonary bypass, the platelet 
count decreases because platelets are trapped in the 
cardiopulmonary bypass circuit or in the pulmonary 
and systemic vascular bed. A decrease in the platelet 
coUnt leads to an increase in postoperative bleeding. 
It also is known that platelets are activated during 
cardiopulmonary bypass, resulting in systemic in- 
flammatory reactions involving neutrophils and 
many inflammatory substances, and that these plate- 
lets also affect the clotting and fibrinolytic systems. 
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Thromboxane A 2 (TxA2) , which is produced pri- 
marily by activated platelets, is a metabolite of 
arachidonates. This substance has a potent vasocon- 
strictive action and is a potent agonist for platelet 
aggregation. Its stable metabolite, TxB2, is reported 
to increase during cardiopulmonary b pass. 12' 13 In 
this study, the TxB 2 level was significantly lower in 
the LPD group than in the control group (Fig. 3). 
Prostacyclin, which is produced primarily by en- 
dothelial cells, antagonizes TxA 2. The level of ó- 
keto-PGFla , a stable metabolite of this substance, 
did not diffe, r significantly between the two groups. 
The ratio of TxB 2 to 6-keto-PGFl~ is often used as 
an indicator of physiologic effects because the bal- 
ance between these two substances i important in 
determining the effects of thromboxaneJ 4 In this 
study, this ratio was significantly lower in the LPD 
group than in the control group for a relatively long 
period, beginning immediately before the release of 
aortic occlusion and ending 12 hours after release. 
Fletcher and colleagues ~s found in animal experi- 
ments thatlTxA 2 was not produced by activated 
platelets alQne but was produced by the interaction 
between leukocytes and platelets. The low ratio of 
TxB 2 to 6-keto-PGFl~ in the LPD group observed in 
this study seems to be attributable not only to the 
removal of platelets but also to the removal of 
leukocytes. When the TxA 2 concentration is higher 
than that of prostacyclin vascular contraction and 
platelet aggregation are accelerated, primarily in the 
lungs, resulting in injury to pulmonary microcircu- 
lation and the onset of respiratory dysfunction. The 
removal of leukocytes and platelets eems to reduce 
respiratory dysfunction after cardiopulmonary b - 
pass by suppressing vascular contraction and plate- 
let aggregation. 
In this study there was no difference between the 
two groups in various complement levels. Comple- 
ment activation during cardiopulmonary b pass is 
known to be caused by the contact of blood with 
foreign matter, such as an artificial ung and extra- 
corporeal circulation circuit. The similar comple- 
ment levels in the LPD and control groups may be 
attributable to the use of the same artificial ung in 
both groupsJ °' 16 
In this study the leukocytes and platelets were 
temporarily removed by plasmapheresis instead be- 
ing removed permanently with a filter. 17 The 
method we used permits the return of sequestered 
leukocytes and platelets into he body after opera- 
tion and seems to be useful in preventing postoper- 
ative infection and reducing postoperative blood 
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representsp < 0.05, Triple asterisk representsp < 0.005 compared with the control group. Data are mean _+ 
SEM. 
loss. The number of leukocytes that could be re- 
moved by plasmapheresis in this study averaged 
3.4 _+ 2.1 × 10 l° cells (119% +_ 46% of the estimated 
number of leukocytes in the circulating blood), 
which is about 10 times the number eported by 
Davies and coworkers 4 3.4 _+ 1.9 × 109 cells/ml 
(equivalent to about 11% of the estimated number 
of leukocytes in the circulating blood). One reason 
for the greater number of leukocytes removed in this 
study is that the duration of removal was rauch 
longer than in previous studies. Another possible 
explanation is that the machine used in previous 
studies was designed primarily for the removal of 
platelets and was therefore l ss effective in removing 
the leukocytes than the machine used for this study. 
The number of platelets removed in this study 
averaged 2.8 + 1.2 × 10 H cells (27% of the esti- 
mated number of platelets in the circulating blood), 
which is greater than the numbers reported by Mohr 
and associates 18 (1 × 1011 cells) and is comparable 
to the numbers reported by Giordano and cowork- 
ers 19 (2.0 × 1011) and Davis and coworkers 4 (3.5 _+ 
1.4 × 101~ cells). These investigators have reported 
that postoperative blood loss and the volume of 
homologous blood transfusion eeded could be 
reduced by collecting plätelets before the start of 
cardiopulmonary b pass and returning them after 
cardiopulmonary b pass. Postoperative blood loss 
also was significantly reduced by this technique in 
this study. 
Levels of TAT and D-dimer, which are indicators 
of abnormal clotting and accelerated fibrinolysis, 
were lower in the LPD group than in the control 
group (Table III). The decreases in these parame- 
ters seem to be related to the decrease in blood loss 
in this group. In addition, the suppression ofpulmo- 
nary microthrombus formation is thought to be 
related to the suppression of respirätory dysfunc- 
tion. In this study we investigated lung injury after 
heart operations with cärdiopulmonary b pass by 
means of analyses of oxygenation and carbon diox- 
ide elimination. Of the conditions howing a venti- 
lation-perfusion imbalance, the condition where 
ventilation is small relative to perfusion reflects 
oxygenation, whereas the condition where perfusion 
is small relative to ventilation reflects carbon dioxide 
elimination. The Pao2, A-aDo2, and RI, which were 
examined as indexes of oxygenation, differed signif- 
icantly between the LPD group and the control 
group until the fourth hour after the release of 
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aortic occlusion but did not differ significantly be- 
tween the two groups from the sixth hour after the 
release of aortic occlusion. The level of PEEP 
needed to obtain an appropriate Pao 2 during post- 
operative intensive care, however, was significantly 
higher in the control group than in the LPD group. 
The reason for this is that the PEEP had to be 
increased to offset the postoperative decrease in 
Pao 2 in these patients. 
In this present study, the EIco» an indicator of 
carbon dioxide elimination, was significantly higher 
in the control group. Bohr's equation of dead spaces 
includes anatomic dead spaces (the volume of the 
airway that is not involved in gas exchange). The 
alveolar dead space ventilation rate indicates the 
relationship between the alveolar ventilation (ex- 
cluding anatomic dead spaces) and the alveolar 
dead space ventilation (alveoli without capillary 
blood flow). If the imbalance between ventilation 
and perfusion becomes erious and if alveoli with 
low perfusion relative to ventilation increase, carbon 
dioxide elimination decreases, resulting in a differ- 
ence in the carbon dioxide tension between the 
arterial blood and alveolar gas. EIco 2 therefore 
indicates the percentage of wasted ventilation (ven- 
tilation in nonperfused areas) relative to the total 
alveolar ventilation. An increase in EIco2 causes an 
exponential increase in respiratory work and results 
in a large load on the cardiovascular system, which 
has little reserve after heart a heart operation] It is 
likely that this value increased in the control group 
in pulmonary areas where perfusion was small rela- 
tive to ventilation because of an increase in pulmo- 
nary microthrombi and other factors. 
The results of this study can be summarized as 
follows: The removal of leukocytes and platelets 
suppressed the activation of leukocytes and platelets 
and the release of reactive substances from these 
cells, leading to the suppression of alveolar and 
interstitial edema, microatelectasis, and other pul- 
monary a~bnormalities. The effect of leukocyte and 
platelet removal on the oxygenation capacity was 
more marked in patients in whom the preoperative 
oxygenatign capacity was lower and in patients in 
whom the duration of cardiopulmonary b pass was 
prolonged for more than 160 minutes. 
The removal of leukocytes and platelets during 
heart operations with cardiopulmonary bypass is 
expected to prevent postoperative deterioration of 
respirato~ function through the mechanisms de- 
scribed h¢re. This technique is particularly recom- 
mended for severely ill patients or patients in whom 
the duration of cardiopulmonary b pass is expected 
to be long. 
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